Global Esophagoscopes and Gastroscopes Market - 2025-2033

The global esophagoscopes and gastroscopes market reached US$ 1.8 billion in 2024 and is expected to reach US$ 2.9 billion by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.

Esophagoscopes are specialized endoscopic instruments used to examine the esophagus, which is the tube that connects the throat to the stomach. These devices are utilized for diagnosing esophageal disorders, such as acid reflux disease (GERD), esophageal cancer, esophageal stricture and foreign body removal. Esophagoscopes can be either rigid or flexible, with flexible esophagoscopes being more commonly used due to their ability to bend and navigate the esophagus comfortably.

Gastroscopes are endoscopic instruments used to examine the stomach and the upper part of the small intestine. These devices are crucial for diagnosing and treating conditions such as gastritis, peptic ulcers, gastric cancers, and H. pylori infection. Similar to esophagoscopes, gastroscopes can be rigid or flexible, with flexible gastroscopes being more widely adopted due to their ability to access various parts of the stomach and the duodenum with ease.

The demand for esophagoscopes and gastroscopes is driven by several key factors, including the increasing prevalence of gastrointestinal (GI) disorders, advancements in endoscopic technology and growing healthcare investments. The increased incidence of gastrointestinal diseases such as gastritis, peptic ulcers, gastroesophageal reflux disease (GERD), esophageal and stomach cancers and other GI disorders significantly fuels the demand for diagnostic and therapeutic endoscopic procedures. For instance, in a recent global study conducted in 33 countries, the authors found that more than 40% of people worldwide have gastrointestinal disorders with higher prevalence in developing countries.

Market Dynamics: Drivers & Restraints

Rising adoption of disposable esophagoscopes and gastroscopes

The rising adoption of disposable esophagoscopes and gastroscopes is significantly driving the growth of the esophagoscopes and gastroscopes market and is expected to drive the market over the forecast period. The COVID-19 pandemic heightened the focus on infection prevention within healthcare settings, especially in endoscopic procedures, where the risk of cross-contamination is high. Reusable esophagoscopes and gastroscopes, if not properly sterilized, can pose serious health risks, including the transmission of hospital-acquired infections (HAIs). The rising preference for disposable esophagoscopes and gastroscopes has led to growing market adoption as hospitals and healthcare providers prioritize patient safety.

For instance, in July 2024, EvoEndo, Inc. released the Model LE 85 Single-Use Gastroscope, providing an additional option for Sedation-Free Transnasal Endoscopy (TNE) of the Upper Gastrointestinal Tract. The Model LE 85 Single-Use Gastroscope is intended to provide optimal patient comfort and physician control when access to the duodenum is not necessary. It has a shorter shaft length and more flexibility for patient safety.

As patients and physicians continue to favor minimally invasive procedures that offer faster recovery times and reduced complication rates, the demand for single-use endoscopes is on the rise. These devices support a variety of diagnostic and therapeutic procedures with next-generation features while offering the added benefit of safety and ease of use. These disposable devices enables doctors to address a larger demands in hospital settings, critical care unit and endoscopic unit.

For instance, in April 2024, Ambu announced 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its therapeutic gastroscope solution, Ambu aScope Gastro Large and Ambu aBox 2. The approval represents an expanded solution offering for surgeons and gastroenterologists who undertake upper GI operations. The expanded endoscope portfolio, including the aScope Gastro and aScope Gastro Large, enables doctors to address a larger variety of demands in hospital settings such as the operating room, critical care unit and endoscopic unit.

Competition from alternative diagnostic technologies

While esophagoscopes and gastroscopes remain crucial for diagnosing and treating gastrointestinal (GI) disorders, the competition from alternative diagnostic technologies is increasingly presenting challenges to the growth of the market. These alternatives often offer non-invasive, cost-effective, and less patient-invasive options that compete with traditional endoscopy procedures.

Non-invasive imaging techniques, such as CT scans (computed tomography), MRI (magnetic resonance imaging) and ultrasound are gaining traction as alternatives to traditional endoscopic procedures. These imaging methods allow physicians to diagnose gastrointestinal conditions without the need for invasive procedures, reducing the risks of complications and improving patient comfort. CT Colonography (Virtual Colonoscopy) is increasingly gaining acceptance due to its shorter procedure time and less patient discomfort.

Capsule endoscopy, where a small camera is ingested by the patient in the form of a pill, is gaining popularity as a non-invasive alternative to traditional endoscopies for examining the small intestine. This method allows physicians to view the GI tract without the need for esophagoscopes or gastroscopes, particularly in cases of obscure GI bleeding or small bowel conditions. For instance, according to Medtronic, the market for capsule endoscopy (e.g., PillCam systems) is growing, particularly in regions like North America and Europe. Which hampers the demand for esophagoscopes and gastroscopes.

Segment Analysis

The global esophagoscopes and gastroscopes market is segmented based on product type, usability, application, end-user and region.

Product Type:

The gastroscopes segment is expected to dominate the esophagoscopes and gastroscopes market share

Gastrointestinal diseases, such as gastritis, peptic ulcers, esophageal varices, gastric cancer and gastroesophageal reflux disease (GERD), have become increasingly common globally. The demand for gastroscopic procedures to diagnose and treat these conditions is significantly higher compared to esophageal disorders, making gastroscopes a dominant segment.

For instance, gastric cancer is one of the most prevalent cancers globally. According to the World Health Organization (WHO), there are over 1 million new cases of gastric cancer diagnosed annually, leading to an increase in gastroscopy procedures. The prevalence of GERD is growing, particularly in Western countries, where the condition affects approximately 20% of the population, driving the demand for gastroscopes for diagnosis and management.

The market for gastroscopes is also dominated by established companies, which continually improve the technology and increase adoption. Major manufacturers are focusing on innovative features, such as high-definition imaging, advanced gastrointestinal endoscopy and single-use gastroscopes, further enhancing the segment's growth. Companies like Olympus Corporation, Pentax Medical, and Fujifilm lead the market with advanced gastroscopes that include high-definition imaging technology for better diagnosis.

For instance, in May 2023, Olympus Corporation announced the FDA clearance of the new EVIS X1 endoscopy system, along with two compatible gastrointestinal endoscopes: the GIF-1100 gastrointestinal videoscope indicated for use within the upper digestive tract and the CF-HQ1100DL/I colonovideoscope indicated for use within lower digestive tract.

Gastroscopes are commonly used for both diagnostic and therapeutic purposes, which increases their usage frequency. They are not only used to examine the upper GI tract, but also for procedures like biopsy, polyp removal, and stent placement, making them indispensable in modern GI practice. Gastroscopy is a standard procedure for diagnosing gastritis, ulcers, and esophageal cancers. The procedure also plays a critical role in endoscopic ultrasound (EUS) for staging cancers, further solidifying its importance in the medical field.

Geographical Analysis

North America is expected to hold a significant position in the esophagoscopes and gastroscopes market share

North America has one of the highest prevalence rates for esophageal and gastrointestinal diseases, which significantly drives the demand for gastroscopic and esophagoscopic procedures. Conditions like GERD (gastroesophageal reflux disease), gastritis, peptic ulcers, esophageal cancers and irritable bowel syndrome (IBS) are increasingly common, leading to higher utilization of diagnostic procedures involving esophagoscopes and gastroscopes.

For instance, according to the National Institute of Health, GERD affects approximately 20% of the U.S. population. This has led to a growing need for gastroscopies for diagnosis and treatment. Esophageal cancer is also prevalent, with the American Cancer Society estimating that in 2025, about 22,070 new esophageal cancer cases diagnosed (17,430 in men and 4,640 in women) and about 16,250 deaths from esophageal cancer (12,940 in men and 3,310 in women). This further contributes to the high demand for gastroscopic procedures for diagnosis and treatment of associated symptoms.

Leading global players such as Olympus, Medtronic, Pentax Medical and Fujifilm have a strong foothold in the North American market, which supports both the supply and adoption of gastroscopes and esophagoscopes. These companies are focused on innovation and meeting the rising demand for advanced imaging systems, robot-assisted surgeries, and disposable endoscopes.

For instance, Olympus Corporation is one of the largest manufacturers of gastroscopes and esophagoscopes, and the company has a significant market share in North America, driven by the growing demand for high-definition, disposable, and minimally invasive technologies. According to the Olympus Corporation, North American market accounts for about 35% of total sales in the GI endoscopy.

Asia-Pacific is growing at the fastest pace in the esophagoscopes and gastroscopes market

Countries in the Asia Pacific are investing heavily in upgrading their healthcare infrastructure, including the adoption of modern medical technologies such as gastroscopes and esophagoscopes. The development of healthcare facilities and endoscopic centers in both urban and rural areas is improving access to endoscopic diagnostic tools including esophagoscopes and gastroscopes.

For instance, in July 2024, FUJIFILM India launched its second-largest endoscopy equipment service center in Mumbai. The center will handle repairs of gastroscopes and high-end processors. The new facility aims to reduce service turnaround times and improve delivery across India.

With the increasing preference for minimally invasive procedures in Asia Pacific, there is a higher demand for gastroscopic and esophagoscopic procedures, as they offer patients faster recovery times, reduced discomfort and fewer risks compared to traditional surgical methods. For instance, single-use gastroscopes are gaining traction in the region, especially in countries like India and China, where there is a rising demand for affordable, effective diagnostic solutions in hospitals and clinics.

Competitive Landscape

The major global players in the esophagoscopes and gastroscopes market include Olympus Corporation, FUJIFILM Holdings Corporation, Ambu A/S, EvoEndo, Inc., EndoMed Systems GmbH, Ottomed Endoscopy, KARL STORZ, Integra LifeSciences Corporation, PENTAX Medical, Erbe Elektromedizin GmbH and among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global esophagoscopes and gastroscopes market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures, and 153 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.